All NewsShow: 1 - 15 of 123 results
WuXi PharmaTech Acquires Abgent
[October 13, 2011] - Abgent brings to WuXi new product lines of biological research reagents for drug discovery and basic research to expand its service offering to its existing customers ...
ShangPharma Subsidiary and Jiangsu Hengrui Form Partnership
[September 15, 2011] - Through the partnership, ChemPartner and Hengrui will initially collaborate on the development of novel therapeutic mAbs in a major therapeutic area ...
Pharmaron Forms a Strategic Partnership with Merck Serono
[September 14, 2011] - The focus of this laboratory will be clinical bioanalysis and biomarker characterization, allowing for the identification of gene mutations among the Chinese population ...
Merck and BGI Establish Strategic Collaboration on Genomic R&D
[September 13, 2011] - Under the agreement scientists from Merck and BGI will work closely together to identify and characterize biomarkers with an emphasis on drug discovery ...
WuXi to Add Clinical Services in China
[August 16, 2011] - WuXi is entering the Chinese clinical trial services sector to help international clients introduce products in the high-growth country, according to Outsourcing-Pharma ...
INC Acquires Australian CRO Trident Clinical Research
[June 01, 2011] - Under the terms of the agreement, Trident will become a wholly owned affiliate of INC Research and will operate as Trident Clinical Research, an INC Research company ...
SGS To Open Mumbai Facility
[May 31, 2011] - This investment will establish a dedicated Life Science Services GMP laboratory, with the ability to provide a wide range of analytical development and quality control testing services ...
Big Pharma: China Market Too Big to Ignore
[May 03, 2011] - China investment will continue throughout 2011 and beyond as big pharma seeks to establish a strong presence in the rapidly growing and lucrative market ...
ICON Continues to Expand in Asia-Pacific Regions
[March 29, 2011] - ICON has opened a new office in Shanghai, China, and is also relocating its Beijing operations to larger premises ...
Shenogen Signs Up ShangPharma to Help Develop Cancer Drug
[March 16, 2011] - The deal involves ShangPharma helping develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment ...
Pharmaron Signs Supply Deal with Isis Pharmaceuticals
[March 16, 2011] - Pharmaron has signed an agreement to provide Isis Pharmaceuticals, Inc. with nucleoside phosphoramidites at quantities up to 100 kg ...
WuXi on the Right Track With 24% Growth in Revenues
[March 10, 2011] - During 2010, WuXi's sales totaled $334.1 million. The company predicts it'll reach around $400 million in 2011, a steady progression from an enterprise ...
Covance Receives AAALAC Accreditation in Shanghai, China
[March 08, 2011] - Covance continues to invest in China to offer its clients a growing range of preclinical safety assessment services to help pharmaceutical and biotechnology companies ...
BMS and WuXi PharmaTech in Analytical and Stabililty Testing Pact
[March 07, 2011] - Under the agreement, WuXi will build, equip and operate a dedicated, fully cGMP-compliant 25,000-square-foot analytical testing facility in Shanghai ...
Marken Adds Clinical Trial Supply Depot in Singapore
[March 04, 2011] - This expansion incorporates a new directly owned, purpose-built Singapore depot to support growing customer demand for Investigational Medical Product distribution ...
